De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
iRhythm Technologies Beheer
Beheer criteriumcontroles 2/4
De CEO iRhythm Technologies' is Quentin Blackford, benoemd in Oct2021, heeft een ambtstermijn van 2.75 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 16.60M, bestaande uit 4.1% salaris en 95.9% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.23% van de aandelen van het bedrijf, ter waarde $ 5.37M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.5 jaar en 7.3 jaar.
Belangrijke informatie
Quentin Blackford
Algemeen directeur
US$16.6m
Totale compensatie
| Percentage CEO-salaris | 4.1% |
| Dienstverband CEO | 3yrs |
| Eigendom CEO | 0.2% |
| Management gemiddelde ambtstermijn | 2.5yrs |
| Gemiddelde ambtstermijn bestuur | 7.3yrs |
Recente managementupdates
Recent updates
Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?
Sep 19
Getting In Cheap On iRhythm Technologies, Inc. (NASDAQ:IRTC) Might Be Difficult
Jul 13iRhythm Technologies (NASDAQ:IRTC) Is Carrying A Fair Bit Of Debt
May 13iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't
Mar 25Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results
Feb 25iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?
Feb 02iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate
Dec 20iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable
Dec 20Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?
Dec 02Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?
Sep 20iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate
Aug 30When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?
Jul 04Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?
Jun 16Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)
May 26iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark
May 08What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?
Mar 27Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?
Feb 25Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?
Nov 24iRhythm falls after reaffirming 2022 guidance
Sep 21iRhythm: Fairly Priced At Current Multiples, No Need To Size Up
Sep 02Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?
Aug 18iRhythm Technologies Q2 results beat estimates, co raises FY 2022 revenue guidance
Aug 04iRhythm Technologies provides FY22 prelims, commercial chief resigns
Jul 19Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$132m |
| Mar 31 2024 | n/a | n/a | -US$130m |
| Dec 31 2023 | US$17m | US$677k | -US$123m |
| Sep 30 2023 | n/a | n/a | -US$105m |
| Jun 30 2023 | n/a | n/a | -US$99m |
| Mar 31 2023 | n/a | n/a | -US$105m |
| Dec 31 2022 | US$8m | US$650k | -US$116m |
| Sep 30 2022 | n/a | n/a | -US$128m |
| Jun 30 2022 | n/a | n/a | -US$131m |
| Mar 31 2022 | n/a | n/a | -US$124m |
| Dec 31 2021 | US$10m | US$163k | -US$101m |
Compensatie versus markt: De totale vergoeding ($USD 16.60M ) Quentin } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 5.54M ).
Compensatie versus inkomsten: De vergoeding van Quentin is gestegen terwijl het bedrijf verliesgevend is.
CEO
Quentin Blackford (45 yo)
3yrs
Tenure
US$16,595,149
Compensatie
Mr. Quentin S. Blackford serves as an Independent Director of Paragon 28, Inc. since August 1, 2022. He serves as President and Chief Executive Officer since October 04, 2021 and serves as Director at iRhy...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 3yrs | US$16.60m | 0.23% $ 4.5m | |
| Chief Medical & Scientific Officer and Executive VP of Product Innovation | 2.5yrs | US$5.32m | 0.016% $ 304.0k | |
| Chief Business & Legal Officer | 2.8yrs | US$5.33m | 0.031% $ 599.0k | |
| Chief Commercial Officer | 2.3yrs | US$5.77m | 0.025% $ 493.0k | |
| Executive Vice President of Business Operations | 1.3yrs | geen gegevens | 0.0023% $ 45.8k | |
| Senior VP of Finance & Chief Accounting Officer | 1.2yrs | geen gegevens | 0.0029% $ 57.0k | |
| Executive VP of Corporate Development & Investor Relations | 5.3yrs | US$3.54m | 0.098% $ 1.9m | |
| Executive VP & Chief Risk Officer | 2.4yrs | geen gegevens | 0.075% $ 1.5m | |
| Director of Investor Relations | no data | geen gegevens | geen gegevens |
2.5yrs
Gemiddelde duur
45yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van IRTC wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.5 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 2.8yrs | US$16.60m | 0.23% $ 4.5m | |
| Independent Director | 7.3yrs | US$233.12k | 0.032% $ 632.7k | |
| Medical Director & Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Independent Director | 7.3yrs | US$240.25k | 0.030% $ 592.0k | |
| Independent Chairman | 8.4yrs | US$286.74k | 0.033% $ 654.4k | |
| Medical Director & Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Independent Director | 6.5yrs | US$230.62k | 0.018% $ 362.2k | |
| Independent Director | 8.6yrs | US$248.12k | 0.034% $ 664.0k | |
| Medical Director & Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Independent Director | 2.9yrs | US$239.97k | 0.020% $ 399.4k | |
| Medical Director & Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens |
7.3yrs
Gemiddelde duur
67yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van IRTC wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.3 jaar).